A subgroup analysis from the IMvigor130 study in patients with upper tract vs. lower tract locally advanced or metastatic urothelial carcinoma treated with atezolizumab plus platinum-based chemotherapy

A subgroup analysis from the IMvigor130 study in patients with upper tract vs. lower tract locally advanced or metastatic urothelial carcinoma treated with atezolizumab plus platinum-based chemotherapy

Bibliographic Details
Main Authors: A. Bamias, M. De Santis, E. Grande, M. Marina, J-R. Li, J. Puente, K. Izumi, J.L. Lee, F. Kose, I. Antonyan, B. Ding, H. Patel, I. Davis
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:European Urology Open Science
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168320361668

Internet

http://www.sciencedirect.com/science/article/pii/S2666168320361668

Similar Items